Ricevi le ultime notizie sulle azioni abrdn Life Sciences con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di HQL

Ultime notizie per

Tekla Life Sciences Invts

abrdn Life Sciences

Tekla Life Sciences

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.

abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors

Mutual Funds

Markets

Press Releases

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

Dividends

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

ASGI

Comments

abrdn Life Sciences Notizie sulle azioni

Notizie

Ultime notizie per

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO